These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3552316

  • 1. The effects of calcium-entry blockade on left ventricular systolic and diastolic function.
    Walsh RA.
    Circulation; 1987 Jun; 75(6 Pt 2):V43-55. PubMed ID: 3552316
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW, Wilffert B, Heynis JB, van de Haar Keuken V, Jonkman FA, van Zwieten PA.
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of heart failure with calcium antagonists].
    Hall D, Dirschinger J, Kraus F, Rudolph W.
    Herz; 1990 Jun; 15(3):179-84. PubMed ID: 2198218
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of calcium channel blocking agents on cardiovascular function.
    Low RI, Takeda P, Mason DT, DeMaria AN.
    Am J Cardiol; 1982 Feb 18; 49(3):547-53. PubMed ID: 7058766
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
    Singh BN.
    Angiology; 1982 Aug 18; 33(8):492-515. PubMed ID: 7051905
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased negative inotropic effect of calcium-channel blockers in hypertrophied and failing rabbit heart.
    Ezzaher A, el Houda Bouanani N, Su JB, Hittinger L, Crozatier B.
    J Pharmacol Exp Ther; 1991 Apr 18; 257(1):466-71. PubMed ID: 1826929
    [Abstract] [Full Text] [Related]

  • 12. Calcium-channel blocking agents.
    Leonard RG, Talbert RL.
    Clin Pharm; 1982 Apr 18; 1(1):17-33. PubMed ID: 6764159
    [Abstract] [Full Text] [Related]

  • 13. The effects of calcium entry blockade on normal and ischemic ventricular diastolic function.
    Walsh RA.
    Circulation; 1989 Dec 18; 80(6 Suppl):IV52-8. PubMed ID: 2688985
    [Abstract] [Full Text] [Related]

  • 14. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.
    Packer M, Kessler PD, Lee WH.
    Circulation; 1987 Jun 18; 75(6 Pt 2):V56-64. PubMed ID: 3552317
    [Abstract] [Full Text] [Related]

  • 15. [Role of calcium antagonists in the pharmacologic treatment of heart insufficiency].
    de Sá ME.
    Rev Port Cardiol; 1989 Jun 18; 8(7-8):547-52. PubMed ID: 2698718
    [Abstract] [Full Text] [Related]

  • 16. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
    Heywood JT.
    Can J Cardiol; 1995 Oct 18; 11(9):823-6. PubMed ID: 7585281
    [Abstract] [Full Text] [Related]

  • 17. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC, Zyvoloski MG, Gross GJ, Brooks HL.
    J Pharmacol Exp Ther; 1984 Aug 18; 230(2):367-75. PubMed ID: 6146711
    [Abstract] [Full Text] [Related]

  • 18. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
    Diamond JA, Krakoff LR, Goldman A, Coplan N, Gharavi A, Martin K, Goldsmith R, Henzlova MJ, Machac J, Phillips RA.
    Am J Hypertens; 2001 Mar 18; 14(3):231-40. PubMed ID: 11281234
    [Abstract] [Full Text] [Related]

  • 19. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R, Yamazaki J, Nagao T.
    J Pharmacol Exp Ther; 1999 May 18; 289(2):831-9. PubMed ID: 10215660
    [Abstract] [Full Text] [Related]

  • 20. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    J Pharmacol Exp Ther; 1995 Oct 18; 275(1):127-35. PubMed ID: 7562540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.